MedPath

iving meaningfully with cancer.

Recruiting
Conditions
cancer survivors, meaning-making, existential issues.
Registration Number
NL-OMON20467
Lead Sponsor
VUMC, VU, LUMC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

Patients may be included when they are:

1. Diagnosed with cancer at least 1 year earlier less than 5 years ago;

Exclusion Criteria

Patients will be excluded when psychiatric disease is present, which may disable the patients' participation in the MCGP sessions, e.g. psychotic behavior (delusions or hallucinations), severe cognitive impairment, current psychiatric treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. The Dutch Personal Meaning Profile (39 items) has 5 scales: religion, dedication to life, fairness of life, goal-orientedness, relationships(á>.80; sufficient validity);<br /><br>2. The Dutch Post Traumatic Growth Scale (21 items) has 5 scales: relationships, viewing new possibilities, personal strength, spirituality, appreciation of life (á>.80; sufficient validity);<br /><br>3. The Dutch Ryff's conceptual wellbeing scale (52 items) has 6 scales: autonomy, environmental mastery, personal growth, positive relationships, purpose in life, self-acceptance (á>.80; sufficient validity).
Secondary Outcome Measures
NameTimeMethod
1. The Dutch Hospital Anxiety and Depression Scale(14 items) has two scales: depression, anxiety(á>.80; sufficient validity);<br /><br>2. The Dutch Beck Hopelessness Scale(20 items) measures hopelessness(á>.80; sufficient validity);<br /><br>3. The Dutch Life Orientation Test(10 items) measures optimism(á>.80; sufficient validity);<br /><br>4. The Mental Adjustment to Cancer scale (40 items) measures specific responses and coping with cancer (á>.80; sufficient validity);<br /><br>5. The Dutch EORTC QLW-C30(30 items) measures tumor-specific health-related quality-of-life, functioning, and physical symptoms(á>.80; sufficient validity;<br /><br>6. EQ-5D;<br /><br>7. TIC-P;<br /><br>8. PRODISQ.
© Copyright 2025. All Rights Reserved by MedPath